Biotech stocks to watch at #SITC17


05-Nov-2017 19:46 PM



      The Society for Immunotherapy of Cancer's (SITC) 32nd Annual meeting from November 8-12, 2017. There will be resources for patient, clinician and researcher to explore. As for investors, there will many biotech company with abstracts presentations to watch. 

       For late-breaking abstracts investors should keep their "I" (pun intended) on watch these three biotech under $10.00:  Infinity Pharmaceuticals Inc (INFI:NASDAQ) from on going trial IPI-549,  Iovance Biotherapeutics Inc  (IOVA:NASDAQ) with six abstracts to be presented, for late-breaking  title: Novel cryopreserved tumor infiltrating lymphoctyes (LN-144).  Inovia Pharmaceuticals Inc (INO:NASDAQ)  for MEDI0457 their phase 1/2 HPV-associated squamous cell carcinoma of the head & neck.  For completed listed late-breaking abstracts titles on the conference website at

     Additional abstracts are from Cellular Therapy biotechnology stocks has been making a run like: Juno Therapeutics Inc (JUNO:NASDAQ), Sangamo Therapeutics Inc (SGMO:NASDAQ), Gilead Sciences Inc (GILD:NASDAQ). Listed on the conference webiste

      Here are more biotech stocks to watch next week: Bristol-Myers Squibb Co (BMY:NYSE), Calithera Biosciences Inc (CALA:NASDAQ), Five Prime Therapeutics Inc (FPRX:NASDAQ), Incyte Corp (INCY:NASDAQ0, NewLink Genetics Corp (NLNK:NASDAQ), and Trillium Therapeutics Inc (TRIL:NASDAQ). For more details on conference webiste



Add Your Comment

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.